Clinical trial
EMD 121974 in Treating Patients With HIV-Related Kaposi's Sarcoma
NCT00006222 · National Cancer Institute (NCI), NIH · Terminated
Key facts
| NCT number | NCT00006222 |
|---|---|
| Title | EMD 121974 in Treating Patients With HIV-Related Kaposi's Sarcoma |
| Official title | A Phase I Trial of EMD 121974 in Patients With HIV Related Kaposi's Sarcoma |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Sarcoma |
| Intervention type | Drug |
| Interventions | cilengitide |
| Enrollment | 30 |
| Start date | Sep 1, 2000 |
| Primary completion | Mar 1, 2001 |
| Completion | Mar 1, 2001 |
| First posted | May 26, 2004 |
| Last update posted | Jun 3, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: